DACT2 and hepatocellular carcinoma: Reduced DACT2 expression and increased β‐catenin signaling have also been reported in advanced metabolic liver disease, suggesting that epigenetic silencing of DACT2 may contribute to a mechanistic continuum from MASLD progression to HCC by permitting unchecked Wnt/β‐catenin activity.75